z-logo
open-access-imgOpen Access
Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in HIV-Positive Patients Ingesting Dabigatran
Author(s) -
Payal Kakadiya,
Robert T. Higginson,
Patricia Pecora Fulco
Publication year - 2017
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02275-17
Subject(s) - cobicistat , ritonavir , dabigatran , pharmacology , medicine , protease inhibitor (pharmacology) , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , atrial fibrillation , viral load , warfarin

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom